Abstract
dc:description.abstractGlucocorticoid excess causes obesity, dyslipidaemia, insulin resistance and hypertension as seen in Cushing's syndrome. In idiopathic obesity, circulating Cortisol levels are not elevated but Cortisol metabolism is altered. liphydroxysteroid dehydrogenase type 1 (11HSD1) is an intracellular enzyme that converts inactive cortisone into active Cortisol. Data from animals suggests that elevated adipose 11HSD1 may generate more glucocorticoid within adipose tissue and be an important mediator of obesity and the associated metabolic consequences (diabetes, dyslipidaemia and hypertension). This thesis addresses whether adipose IIHSD1 is elevated in human obesity, investigates if this occurs through altered transcription, and assesses the downstream impact (changes in downstream target genes and metabolic outcomes). Regulation of 11HSD1 mRNA in animal and cell models (eg by high fat feeding, insulin, and PPAR agonists), and putative control of enzyme direction by NADPH generation (via hexose-6-phosphate dehydrogenase), suggest a dynamic role for 11HSD1 in the adaptive response of adipose to altered nutrition. The importance of these potential regulators in lean and obese humans is also addressed in this thesis.
Degree
thesis:*- Grantor dc:publisher
- The University of Edinburgh
- Year dc:date.issued
- 2006
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Wake, Deborah Jane
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- http://hdl.handle.net/1842/27586